CSCS
Smart ovarian cancer surgery
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
Disclaimer: this app is designed by and for ovarian cancer surgeons. If you downloaded this application as a patient please talk to your doctor for advice.
The aim of this APP is to help doctors in the prognosis of the achievement of suboptimal surgery in the surgical treatment of advanced ovarian cancer, with the possible repercussion that this could have on the choice of the most appropriate therapeutic strategy.
We present 2 prognostic models, R3 and R4, based on the determination of the Peritoneal Carcinomatosis Index (PCI) obtained in the preoperative period with the Computerized Axial Tomography (CT-scan), the PCI obtained by Laparoscopy staging, the one obtained in the surgical exploration of the peritoneal cavity (operative PCI), as well as in the existence of intestinal obstructive signs in any of the aforementioned diagnostic tests. The R3 model includes exclusively pre-operative diagnostic tests: CT-scan and Laparoscopy if it had been performed, and the possible signs of total or partial intestinal obstruction. The R4 model adds to the above the result of the operative PCI.
The models R3 and R4 can be considered as a diagnostic test that encompasses the other mentioned tests. As such, they have their own Sensitivity and Specificity, and establish an initial prognosis based on these diagnostic indices. But obtaining a definitive diagnosis (Final Prognosis or Positive Predictive Value) of the possibility of suboptimal surgery requires the integration of the prevalence of existing suboptimal surgery, according to the general formula of Bayes' Theorem. This prevalence is represented by the percentage of suboptimal surgery that has until that moment who applies the model to their specific patient.
Every prognostic model offers explicit results along with a spectrum of uncertain results. The R3 and R4 models are no exception. Therefore, it is advised that for suboptimal surgery, a Positive predictive value of up to 35% be considered as “UNLIKELY suboptimal citoreductive surgery”, between 35% and 69% as “UNCERTAIN”, and 70% thereafter as “PROBABLE suboptimal citoreductive surgery”.
All prognostic model must be validated by each doctor that employs it, before considering it effective for its habitual use. Therefore, it is important that each user verifies the extent to which the final prognosis obtained by the model coincides with the final result of suboptimal surgery in a series of cases in which it has been applied.
Hide..
Show more..
The aim of this APP is to help doctors in the prognosis of the achievement of suboptimal surgery in the surgical treatment of advanced ovarian cancer, with the possible repercussion that this could have on the choice of the most appropriate therapeutic strategy.
We present 2 prognostic models, R3 and R4, based on the determination of the Peritoneal Carcinomatosis Index (PCI) obtained in the preoperative period with the Computerized Axial Tomography (CT-scan), the PCI obtained by Laparoscopy staging, the one obtained in the surgical exploration of the peritoneal cavity (operative PCI), as well as in the existence of intestinal obstructive signs in any of the aforementioned diagnostic tests. The R3 model includes exclusively pre-operative diagnostic tests: CT-scan and Laparoscopy if it had been performed, and the possible signs of total or partial intestinal obstruction. The R4 model adds to the above the result of the operative PCI.
The models R3 and R4 can be considered as a diagnostic test that encompasses the other mentioned tests. As such, they have their own Sensitivity and Specificity, and establish an initial prognosis based on these diagnostic indices. But obtaining a definitive diagnosis (Final Prognosis or Positive Predictive Value) of the possibility of suboptimal surgery requires the integration of the prevalence of existing suboptimal surgery, according to the general formula of Bayes' Theorem. This prevalence is represented by the percentage of suboptimal surgery that has until that moment who applies the model to their specific patient.
Every prognostic model offers explicit results along with a spectrum of uncertain results. The R3 and R4 models are no exception. Therefore, it is advised that for suboptimal surgery, a Positive predictive value of up to 35% be considered as “UNLIKELY suboptimal citoreductive surgery”, between 35% and 69% as “UNCERTAIN”, and 70% thereafter as “PROBABLE suboptimal citoreductive surgery”.
All prognostic model must be validated by each doctor that employs it, before considering it effective for its habitual use. Therefore, it is important that each user verifies the extent to which the final prognosis obtained by the model coincides with the final result of suboptimal surgery in a series of cases in which it has been applied.
Screenshots
User Rating
0 out of 5
0 ratings in Italy
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
The Cancer App
Help at Hand
|
0
|
2 months ago | |
MyJourney: Guide to your Care
|
0
|
3 months ago | |
ChemoSafe
Assessing chemotherapy safety
|
0
|
1 year ago | |
Ovarian Cancer Manager
|
0
|
8 months ago | |
Breast Cancer [BC]
From @Point of Care
|
0
|
1 month ago | |
BEE - Belamaf Eye Exam
|
0
|
2 years ago | |
Any Mountain
|
0
|
1 year ago | |
Enzian Classification | MIS
MIS Academy Classification
|
0
|
1 year ago | |
Get Me Back: Fit after cancer
|
0
|
1 month ago | |
MFHP Cancer
|
0
|
9 months ago |
Show More
Revenue and Downloads
Gain valuable insights into CSCS performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Esparciapps COOP.V
- Languages
- English
- Recent version
- 1.0.1 (3 years ago )
- Released on
- Jan 3, 2021 (3 years ago )
- Also available in
- Spain, Portugal, Japan, South Korea, Kuwait, Kazakhstan, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Poland, India, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Ukraine, United States, Vietnam, South Africa, Algeria, Austria, Australia, Belgium, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Dominican Republic, Italy, Ecuador, Egypt, Finland, France, United Kingdom, Greece, Hong Kong, Hungary, Indonesia, Ireland, Israel, United Arab Emirates, Azerbaijan
- Last updated
- 1 week ago